Vertex and NHS England reach impasse over cystic fibrosis drug price

11:13 EDT 6 Jul 2018 | Pharmaceutical Technology

Cystic fibrosis (CF)-focused Vertex has declared that its recent negotiations with NHS England regarding the price of its drug Orkambi...
Read More...

The post Vertex and NHS England reach impasse over cystic fibrosis drug price appeared first on Pharmaceutical Technology.

Original Article: Vertex and NHS England reach impasse over cystic fibrosis drug price

More From BioPortfolio on "Vertex and NHS England reach impasse over cystic fibrosis drug price"